Kevin Tang Reports a $13.59 Million $AUPH Buy

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Aurinia Pharmaceuticals $AUPH – Kevin Tang filed a Form 4 for a $13.59 million buy.

That’s a deck-shaking insider purchase in biotech that's already breaking out of a tight coil 

📌 Matador Resources $MTDR – Chairman & CEO Joseph Foran filed for $246,000.

Notable that an executive is buying small-cap E&P shares just as crude tests support.

Here’s The Hot Corner, with data from August 5, 2025:

Click the table to enlarge it.

📌 Immunocore $IMCR – Wellington Management lifted its holding from 9.00% to 10.20% via a 13G.

Crossing 10% in a thin-floated name – big tell.

📌 Apogee Therapeutics $APGE – Wellington also moved from 8.25% to 10.60% per another 13G.

That’s more biotech conviction from a top-tier fund.

📌Last but not least, insiders also showed up in a handful of regional banks:

• ConnectOne Bancorp $CNOB
• Heritage Commerce $HTBK
• Shore Bancshares $SHBI
• Merchants Bancorp $MBIN